{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:08:24Z","timestamp":1783631304392,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["LP130100703"],"award-info":[{"award-number":["LP130100703"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["130100703"],"award-info":[{"award-number":["130100703"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nucmedbio.2019.12.007","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T11:33:00Z","timestamp":1576841580000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)"],"prefix":"10.1016","volume":"84-85","author":[{"given":"Zheng","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Mardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damion H.R.","family":"Stimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-anne","family":"Migotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Reutens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nucmedbio.2019.12.007_bb0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.22734","article-title":"Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway","volume":"63","author":"Ott","year":"2015","journal-title":"Glia"},{"issue":"19","key":"10.1016\/j.nucmedbio.2019.12.007_bb0010","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.1604453113","article-title":"Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites","volume":"113","author":"Breda","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.nucmedbio.2019.12.007_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA-Cancer J Clin"},{"issue":"7\u20138","key":"10.1016\/j.nucmedbio.2019.12.007_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-0463.2008.01163.x","article-title":"Tumor dormancy and immunoescape","volume":"116","author":"Quesnel","year":"2008","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.nucmedbio.2019.12.007_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.nucmedbio.2016.02.001","article-title":"Design and automated production of 11C-alpha-methyl-l-tryptophan (11C-AMT)","volume":"43","author":"Huang","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.007_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/srep16417","article-title":"Development of 1-N-11C-methyl-l- and -d-tryptophan for pharmacokinetic imaging of the immune checkpoint inhibitor 1-methyl-tryptophan","volume":"5","author":"Xie","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nucmedbio.2019.12.007_bb0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11307-016-1024-z","article-title":"Improved radiosynthesis and biological evaluations of L- and D-1-[18F]fluoroethyl-tryptophan for PET imaging of IDO-mediated kynurenine pathway of tryptophan metabolism","volume":"19","author":"Xin","year":"2017","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.007_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2017.05.001","article-title":"Preparation and evaluation of L- and D-5-[18F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases","volume":"51","author":"Tang","year":"2017","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2019.12.007_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/acs.jmedchem.7b01245","article-title":"Discovery of 7-[18F]fluorotryptophan as a novel positron emission tomography (PET) probe for the visualization of tryptophan metabolism in vivo","volume":"61","author":"Zlatopolskiy","year":"2018","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.nucmedbio.2019.12.007_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.jcbfm.9600199","article-title":"In vivo uptake and metabolism of \u03b1-[11C]methyl-l-tryptophan in human brain tumors","volume":"26","author":"Juh\u00e1sz","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.nucmedbio.2019.12.007_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-010-0327-1","article-title":"Differential kinetics of \u03b1-[11C]methyl-l-tryptophan on PET in low-grade brain tumors","volume":"102","author":"Juh\u00e1sz","year":"2011","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2019.12.007_bb0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0969-8051(94)00116-2","article-title":"Asymmetric radiosynthesis of \u03b1-[11C]methyl-l-tryptophan for PET studies","volume":"22","author":"Mzengeza","year":"1995","journal-title":"Nucl Med Biol"},{"issue":"8","key":"10.1016\/j.nucmedbio.2019.12.007_bb0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0969-8051(96)00127-8","article-title":"A high-yield and simplified procedure for the synthesis of \u03b1-[11C]methyl-l-tryptophan","volume":"23","author":"Chakraborty","year":"1996","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2019.12.007_bb0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1042\/BST0370408","article-title":"Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase","volume":"37","author":"Rafice","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"10.1016\/j.nucmedbio.2019.12.007_bb0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0968-0896(03)00046-4","article-title":"Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors","volume":"11","author":"Hu","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2019.12.007_bb0080","series-title":"Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use. WO2015121812A1","author":"Crosignani","year":"2015"},{"issue":"43","key":"10.1016\/j.nucmedbio.2019.12.007_bb0085","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1016\/S0040-4020(00)00773-0","article-title":"Hydroboration and Suzuki\u2013Miyaura coupling reactions with the electronically modulated variant of an ynamine: the synthesis of (E)-\u03b2-arylenamides","volume":"56","author":"Witulski","year":"2000","journal-title":"Tetrahedron"},{"issue":"35","key":"10.1016\/j.nucmedbio.2019.12.007_bb0090","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1002\/anie.201604152","article-title":"Direct access to \u03b1,\u03b1-difluoroacylated arenes by palladium-catalyzed carbonylation of (hetero)aryl boronic acid derivatives","volume":"55","author":"Andersen","year":"2016","journal-title":"Angew Chem-Int Edit"},{"issue":"12","key":"10.1016\/j.nucmedbio.2019.12.007_bb0095","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/ol070889p","article-title":"Synthesis of DEFG ring of complestatin and chloropeptin I:highly atropdiastereoselective macrocyclization by intramolecular Suzuki-Miyaura reaction","volume":"9","author":"Jia","year":"2007","journal-title":"Org Lett"},{"issue":"5","key":"10.1016\/j.nucmedbio.2019.12.007_bb0100","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bmc.2017.01.025","article-title":"Lynamicin D an antimicrobial natural product affects splicing by inducing the expression of SR protein kinase 1","volume":"25","author":"Sigala","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.nucmedbio.2019.12.007_bb0105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ajoc.201300128","article-title":"Copper-catalyzed N-alkynylation of N-tert-butyloxycarbonyl (Boc)-protected indoles","volume":"2","author":"Song","year":"2013","journal-title":"Asian J Org Chem"},{"issue":"4","key":"10.1016\/j.nucmedbio.2019.12.007_bb0110","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acs.jnatprod.6b01152","article-title":"Identification of pyridinium with three indole moieties as an antimicrobial agent","volume":"80","author":"Okada","year":"2017","journal-title":"J Nat Prod"},{"issue":"24","key":"10.1016\/j.nucmedbio.2019.12.007_bb0115","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/jacs.7b03131","article-title":"Derisking the Cu-mediated 18F-fluorination of heterocyclic positron emission tomography radioligands","volume":"139","author":"Taylor","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"21","key":"10.1016\/j.nucmedbio.2019.12.007_bb0120","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1002\/ejoc.201300133","article-title":"One-pot synthesis of camalexins and 3,3\u2032-biindoles by the Masuda borylation\u2013Suzuki arylation (MBSA) sequence","volume":"2013","author":"Tasch","year":"2013","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.nucmedbio.2019.12.007_bb0125","first-page":"62","article-title":"Investigation on the impact of three different QMA cartridges on the radiosynthetic yields of [18F]fluoromethyl tosylate","author":"Stimson","year":"2019","journal-title":"J Label Compd Radiopharm"},{"issue":"6","key":"10.1016\/j.nucmedbio.2019.12.007_bb0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.7150\/thno.19371","article-title":"Synthesis of 5-[(18)F]fluoro-\u03b1-methyl tryptophan: new Trp based PET agents","volume":"7","author":"Giglio","year":"2017","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.nucmedbio.2019.12.007_bb0135","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1016\/j.ejmech.2011.08.044","article-title":"Structure\u2013activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors","volume":"46","author":"Huang","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"26","key":"10.1016\/j.nucmedbio.2019.12.007_bb0140","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1021\/jo971640w","article-title":"Enantiospecific synthesis of optically active 6-methoxytryptophan derivatives and total synthesis of tryprostatin A1","volume":"62","author":"Gan","year":"1997","journal-title":"J Org Chem"},{"issue":"30","key":"10.1016\/j.nucmedbio.2019.12.007_bb0145","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1002\/ange.201404436","article-title":"A general copper-mediated nucleophilic 18F fluorination of Arenes","volume":"126","author":"Tredwell","year":"2014","journal-title":"Angewandte Chemie"},{"issue":"45","key":"10.1016\/j.nucmedbio.2019.12.007_bb0150","doi-asserted-by":"crossref","first-page":"14313","DOI":"10.1021\/jacs.5b10119","article-title":"Ni\/Cu-catalyzed defluoroborylation of fluoroarenes for diverse C\u2013F bond functionalizations","volume":"137","author":"Niwa","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"24","key":"10.1016\/j.nucmedbio.2019.12.007_bb0155","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/jacs.7b03131","article-title":"Derisking the Cu-mediated 18F-fluorination of heterocyclic positron emission tomography radioligands","volume":"139","author":"Taylor","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.nucmedbio.2019.12.007_bb0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.nucmedbio.2019.12.007_bb0165","first-page":"1030","article-title":"Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals","volume":"24","author":"Dischino","year":"1983","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2019.12.007_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nucmedbio.2016.03.001","article-title":"Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging","volume":"43","author":"Henrottin","year":"2016","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119305074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119305074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:49:17Z","timestamp":1778575757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805119305074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"alternative-id":["S0969805119305074"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.12.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}